GLX technology

IDE Approval Has Been Granted by FDA for Edwards New Glx Technology Platform
Jun 11, 2012
The US Food and Drug Administration (FDA) has granted a conditional investigational device exemption (IDE) approval to Edwards Lifesciences' new GLX technology platform. Based on the IDE approval, the company will commence a clinical ...

Tags: FDA, IDE, Lifesciences, GLX technology